Skip to main content
. 2016 Oct 28;22(40):8967–8977. doi: 10.3748/wjg.v22.i40.8967

Table 3.

Summary of adverse effects (mean ± SD)

Case Creatinine at baseline (mg/dL) eGFR at baseline (mL/min/1.73 m2) Adverse effects (grade) Onset time of grade 2 adverse effects
1 1.19 45.6 Elevated creatinine (3) Week 2
Anorexia (2) Week 2
2 0.70 83.7 Elevated creatinine (2) Week 2
Anorexia (2) Week 3
3 1.00 56.9 Elevated creatinine (2) Week 3
4 0.75 80.2 Elevated creatinine (2) Week 3
5 0.63 70.2 Elevated creatinine (2) Week 4
Anorexia (1)
6 0.43 111.5 Anorexia (1)
Elevated creatinine (1)